The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

Human growth hormone (HGH) is a hormone that’s essential to our development. Most people produce enough HGH throughout their lifetime. But for those with a deficiency in growth hormone (or a few other ...

The US Food and Drug Administration (FDA) has approved lonapegsomatropin (Skytrofa, Ascendis Pharma), the first weekly subcutaneous injectable growth hormone for children with growth hormone ...

(Reuters) -The U.S. Food and Drug Administration has approved Pfizer Inc and partner OPKO Health Inc's treatment for growth hormone deficiency in children, the companies said on Wednesday. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

Market Report by Application, Distribution Channel, Route of Administration and Company Analysis, 2025-2033" has been added ...

If you’re looking for a natural way to increase the body’s production of HGH (without using expensive injections), then you’ve likely heard of HGH supplements. Whether you’re looking to reduce the ...

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable and needle-free formats. SCOTTSDALE, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Disclaimer: ...